20.1 C
New York

Tag: Globally

Bitcoin Options Expire

The bitcoin and ethereum options on Deribit, one of the largest crypto derivatives exchange, expired earlier today. This month saw the largest open interest in...

Top News

Permission.io migrating to Polygon network to globally scale Web3 advertising

The move will enable Permission to further accelerate its mission to empower users worldwide to own and monetize their data.  Permission.io, the leading...

CapitalXtend Introduces Gold Coin Rewards for its VIP Partners

CapitalXtend, the leading investment platform that empowers its clients and partners with robust and intuitive trading tools has introduced Gold coin rewards to honor its VIP Partners for their long-held association, trust, and remarkable contributions.

Tag Template - News Hub PRO CoinGenius Hosts Virtual Crypto Event The Road To Mass Adoption

The multi-asset platform has globally announced the distribution of Gold coins for its partners to celebrate their impressive achievements under the CapitalXtend Partners Program. The reward distribution is a token of appreciation for all the dedicated partners whose performance and commitment has reached outstanding levels and has boosted CapitalXtend's global community of successful investors.

CapitalXtend's Founder & CEO, Mr. Philippos Tsangaris, says:

“We saw the partner program accelerate in 2021, and the recent quarters continue to present a strong track record of growth. CapitalXtend saw a 214% increase in the number of new registrations and it is only fair to make the program more rewarding in order to embrace and appreciate our esteemed partners.”

About the Partnership Program

CapitalXtend's Partners Program is a revolutionary opportunity to earn accelerating income through referrals. Equipped with contemporary technology solutions and tailored to match the needs of potential partners, the program provides best-in-industry rebates, tools, and instant withdrawals.

About CapitalXtend

CapitalXtend is a new-age investment platform that has enabled a state-of-the-class trading journey for over thousands of traders and investors. Since 2005 the feature-rich platform provides 300+ instruments across Forex, Stock CFDs, Spot Metals, CFD Indices, Spot Energies, and Cryptocurrencies along with years of experience & guidance onboard.  

It is a globally trusted financial service provider committed to revolutionizing the trading experience in the financial world with best-in-class offerings, technology-oriented services, the safety of funds, and 24/7 dedicated customer support.

Disclaimer:

CapitalXtend Group Ltd is incorporated in the Republic of Kazakhstan, registered as a Financial Services Provider with the Ministry of Economy, and regulated by the Financial Commission.

Media Contact

Company Name :- CapitalXtend Group Ltd

Email Id :- marketing@capitalxtend.com

Company Website :- https://www.capitalxtend.com


Avance Clinical Finalist for Informa Pharma Intelligence Awards 2022 – Best Contract Research Organization in APAC

Tag Template - News Hub PRO CoinGenius Hosts Virtual Crypto Event The Road To Mass Adoption

ADELAIDE, AUS, Apr 19, 2022 - (ACN Newswire) - Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has been selected as a finalist for the Best Contract Research Organization in APAC by Informa Pharma Intelligence.

Tag Template - News Hub PRO CoinGenius Hosts Virtual Crypto Event The Road To Mass Adoption

Avance Clinical has undergone significant expansion in recent years, including new offices in Sydney and Melbourne to accommodate the growing clinical team in Australia.

The award winner will be announced on 1 September 2022. The finalists are:
- Avance Clinical
- Calyx
- CMIC Group
- EPS
- ICON
- Parexel
- Syneos Health

Avance Clinical's CEO Yvonne Lungershausen said:

"Avance Clinical is extremely pleased to be selected as a finalist for this prestigious award. It is a credit to our amazing customer-focused team for delivering the CRO excellence that has been recognized by the Informa Pharma Intelligence award judges.

"Avance Clinical has a global reputation for agile clinical solutions to support accelerated clinical development for our international biotech clients. We are very proud of our growth and success in APAC in recent years."

According to Informa Pharma Intelligence:

This Award is to recognize CROs that provide full or specialist services to their clients and which have an office in either in Japan or the Asia region including Australia.

Judging considers the quality of services and relationships built with clients and pays particular attention to the innovative patient recruitment strategies the CRO has brought to the table.

The award is based on achievements in the 2021 calendar year.

Core areas judged include:
- The particular capabilities and strengths the CRO offers
- How the company has delivered results that exceed sponsor expectations
- Innovations in patient recruitment strategy has the CRO brought to its partner
- How it has improved its performance, for example, in its quality of data, timelines and transparency
- The steps the company is taking towards streamlining data collection and reporting

To find out more please visit: https://pharmaintelligence.informa.com/events/awards/japan-awards-2022/shortlist-2022

Avance Clinical recently secured a significant investment from global private equity firm, The Riverside Company (Riverside), to support further regional and global expansion. The investment values the company in excess of $200m.

"With the support of Riverside and its powerful global footprint and deep healthcare experience, Avance Clinical will execute on its regional and international expansion plans organically and via acquisitions," said Lungershausen.

Avance Clinical is the Australian-owned CRO that provides global regulatory standard clinical research services across all phases to the local and international biopharma industry.

The company is also accredited as a gene technology CRO under the Office of the Gene Technology Regulator (OGTR) which has allowed it to expand into clinical trials for vaccines and GMO therapies.

"We have shown, with our high growth and industry-leading repeat business rates that our focus on gold standard technology paired with solution-orientated clinical experts is the mix our biopharma clients require in this fast-moving, competitive and high-stakes sector," said Lungershausen.

Avance Clinical has been recognised for the past two consecutive years with the prestigious Frost & Sullivan CRO Best Practices Award.

Find out more:
- Learn about the Australian Advantage here https://www.avancecro.com/the-australian-advantage/
- Read more about Avance Clinical's cell and gene therapy capabilities here www.avancecro.com/avance-clinical-featured-in-endpoints-news-on-cell-gene-therapy-capabilities/
- For more information about the benefits of running your next study with Avance Clinical contact us: enquiries@avancecro.com

About Avance Clinical

Avance Clinical is the largest premium full-service Australian CRO delivering quality clinical trials, with globally accepted data, in Australia and New Zealand for international biotechs. The company's clients are biotechs in their early phases of drug development that need fast, agile, and adaptive solution-oriented clinical research services.

Frost & Sullivan Awards
Avance Clinical, a Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient for the past two years, has been providing CRO services in the region for 24 years.

Pre-clinical through to Phase 1 and 2
Avance Clinical offers pre-clinical services with their experienced ClinicReady team right through to Phase 1 and 2 clinical services leveraging significant Government incentive rebates of up to 43.5% and rapid start-up regulatory processes.

With experience across more than 105 indications, the CRO can deliver world-class results and high-quality internationally accepted data for FDA and EMA review.

Technology
Avance Clinical uses state-of-the-art technology and gold standard systems across all functional areas to provide clients with the most effective processes. Medidata, Oracle, and Medrio are just some of the technology partners.

Media Contacts:
Avance Clinical
Chris Thompson
media@avancecro.com

Copyright 2022 ACN Newswire. All rights reserved. www.acnnewswire.comAvance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has been selected as a finalist for the Best Contract Research Organization in APAC by Informa Pharma Intelligence.

Top Data and Analytics Players from ASEAN to Assemble for the 3rd Global Edition of World Data & Analytics Show

Tag Template - News Hub PRO CoinGenius Hosts Virtual Crypto Event The Road To Mass Adoption

Singapore, Apr 13, 2022 - (ACN Newswire) - The 3rd global edition of World Data & Analytics Show, with a special focus on the ASEAN market, is all set to take place virtually on 19 April 2022. The event will gather top experts from ASEAN region where they will shed insights on analytics to improve an organization's operational performance, boost consumer engagement, and simplify supply chains.

Tag Template - News Hub PRO CoinGenius Hosts Virtual Crypto Event The Road To Mass Adoption

Notable speakers include Celine Le Cotonnec, Vincent Toh, Hartnell Ndungi, Juan Intan Kanggrawan, Benedict Benoit, Bhaskar Vetrimani, Dr. Shidan C Murphy, Sam Majid, Bhaskar Vetrimani, Meenakshi Nissim Ghoge, Balaji Jayaraman, Martijn Wieriks, Ram Kumar & more. These experts will present eye-opening keynotes, government and enterprise use-case presentations, exciting product showcases, take part in panel discussions and tech talks to discuss the latest challenges and explore data-powered solutions.

Businesses in the ASEAN region are embracing data analytics to help them grow post-Covid-19. The diversified economic environment of the region adds further difficulties to decision-making. Data analytics has been shown to be an efficient method for identifying the aspects that produce value for regional businesses. This digital revolution aids in the improvement of efficiency and business operations.

ASEAN companies are facing unique challenges in optimizing their business processes while balancing privacy and compliance. However, the use of data analytics allows companies to foresee trends, improve operations, and streamline operations. By increasing efficiency and productivity, data analytics can help ASEAN companies become more competitive globally.

"According to our research, more than 90 percent of APAC business executives believe that data analytics is important for their organizations to remain performant, but less than 19 percent of enterprises across the region have achieved maturity in analytics. At Alteryx, we are committed to empowering everyone and anyone to make data-driven decision and advancing organizations' capability in analytics. Join us at our session in this year's World Data and Analytics Show 2022, to uncover how your organization can transform from being data-rich to data-driven," stated Suganthi Shivkumar, VP of Asia, Alteryx.

"Dataiku will show you how extraordinary AI for everyday purpose is brought to life in this edition of the World Data and Analytics Show 2022. As a lead sponsor, we await the opportunity to connect with attendees and discuss how to realize their AI strategy at scale and speed; no matter the stage of AI or analytics maturity. Meet us at our booth to find out more on how Data Science meets Everyday Use!," said Jiunn Hao; Director, APAC Partnerships, Dataiku.

Among the early adopters of future tech, groundbreaking experts taking the center stage include:
- Celine Le Cotonnec, Chief Data Innovation Officer, Bank of Singapore
- Vincent Toh, Snr Manager, Sales Engineering, Alteryx ASIA, Singapore
- Benedict Benoit, Area Vice President, Collibra, Australia
- Bhaskar Vetrimani, Head of Sales & Business Development, APAC, Lingaro
- Hartnell Ndungi, Chief Data Officer, Absa Bank Kenya PLC, Kenya
- Grant Case; Director of Sales Engineering, Dataiku, Australia
- Juan Intan Kanggrawan, Head of Data Analytics and Digital Products, Jakarta Smart City, Indonesia
- Ankit Singi, Data Science Implementation Manager, Dataiku, Singapore
- Sam Majid, CTIO, MCMC Malaysia
- Benedict Benoit, Area Vice President, APAC, Collibra, Australia
- Srinivasan Sankar, Enterprise Data and Analytics Leader, The Hanover Insurance Group, United States
- Igor Rotin, Chief Data Scientist, Liebherr Aerospace and Transportation, Germany
- Meenakshi Nissim Ghoge, Director - Data & Analytics, Mondelēz International, Singapore
- Katrina Briedis, Sr. Product Marketing Manager, APAC Denodo
- Balaji Jayaraman, Senior Vice President- Head of Data and Analytics (APAC), Citi Bank, Singapore
- Martijn Wieriks, Chief Data Officer, JULO, Indonesia
- Dr. Shidan C Murphy, Director of Data Analytics, Altair, APAC
- Bhaskar Vetrimani, Head, Sales and Business Development, Lingaro APAC
- Ram Kumar, Chief Data & Analytics Officer, Cigna, Singapore; to name a few.

"Businesses are facing increasing expectation to utilize data analytics to drive decision-making, improve service levels and generate new revenue streams. However, ASEAN businesses need to overcome limitations in data (data literacy and digital literacy), policy and capability to fully utilize the potential of data analytics," stated Mithun Shetty, CEO, Trescon.

The event will be hosted on the virtual events platform Vmeets to help participants network and conduct business in an interactive and immersive virtual environment. Participants can also engage with the speakers during Q&A sessions and network with solution providers/sponsors at their virtual exhibition booths, private consultation rooms and meeting tables.

World Data & Analytics Show - ASEAN is officially sponsored by:
- Headline Sponsor - Alteryx
- Lead Sponsor - Dataiku | TechData
- Platinum Sponsor - Collibra
- Gold Sponsors - Denodo & Lingaro
- Silver Sponsors - Altair & Cloudera
- Bronze Sponsor - Snowflake & EnterpriseDB

About World Data & Analytics Show

World Data & Analytics Show is a thought leadership-driven, business-focused, global series of events that takes place in strategic locations across the world.

As part of the world tour, this ASEAN edition is virtually gathering pre-qualified C-Suite IT Leaders, Business Analysts, Data Analytics Heads, Heads of Business Intelligence, Industry Practitioners, IT Decision Makers and Experts in Data & Analytics among others from cross industry verticals across ASEAN region.

The show would feature exciting keynotes, government and enterprise use-case presentations, product showcases, panel discussions and tech talks to discuss the latest challenges and explore the latest applications in data powered solutions.

About Trescon

Trescon is a global business events and consulting firm that provides a wide range of business services to a diversified client base that includes corporations, governments, and individuals. Trescon specializes in producing highly focused B2B events that connect businesses with opportunities through conferences, road shows, expos, demand generation, investor connect and consulting services.

For further details, please contact:
Jagriti Jaiswal
Corporate Communications,
Trescon | marketing@tresconglobal.com

Copyright 2022 ACN Newswire. All rights reserved. www.acnnewswire.comThe 3rd global edition of World Data & Analytics Show, with a special focus on the ASEAN market, is all set to take place virtually on 19 April 2022.

Crypto-Upvotes Is Expanding Its Business by Entering the Asian Market

Tag Template - News Hub PRO CoinGenius Hosts Virtual Crypto Event The Road To Mass Adoption

SYDNEY, Apr 13, 2022 - (ACN Newswire) - Crypto marketing agency Crypto-Upvotes is starting to conquer the Asian market by offering advertisements for crypto projects on billboards in Greater China region. The company will also offer promotions on local social networks such as Wechat & Tiktok. The company is expected to offer similar services in Japan and Korea in a month after the full launch in Greater China.

"The popularity of cryptocurrencies in Greater China region is growing every day, and the Asian market has not yet reached its potential. Cryptocurrencies in this region are only at the stage of development and implementation into normal life", says Crypto-Upvotes CEO Daniel Lazovsky.

The decision to expand into the Asian market was made after the successful expansion of Western markets. Until 2022, the company was engaged in advertising and promotion in the United States and Europe. In particular, at the end of last summer Crypto-Upvotes started advertising cryptocurrency projects on billboards across the United States. The first billboards appeared in downtown New York City. To date, the company offers placement on more than 300,000 billboards across the U.S.

"We're taking a really innovative approach", claims Daniel Lazovsky. "While the overwhelming majority of the advertising for cryptocurrency projects is online, we offer offline promotion. It may sound clumsy, but it works!" According to the CEO, this approach provides a comprehensive promotion. A person sees an advertisement for a cryptocurrency project online, then gets behind the wheel - and observes it on a billboard.

Billboard advertisements are a very popular form of advertising in Greater China region. Therefore, in all major cities, billboards can be seen literally on the walls of every house. The marketing team assumes that such a way of advertising cryptocurrency projects will fit organically into the overall picture of the local advertising market and bring the expected effect.

As for online activities, the company pays special attention to WeChat, the main communication software used by local Internet users. It is the local equivalent of WhatsApp. WeChat is known for having various groups about cryptocurrencies. The company will leverage this opportunity by creating new groups for its customers.

Also, many people in Greater China region like to use Tiktok, which is equivalent to YouTube in other countries. There are many Internet celebrities on Tiktok. The marketing team is considering involving different well-known personalities to create influencer marketing campaigns for its customers.

Crypto-Upvotes have been in the cryptocurrency world since 2014. In addition to billboard advertising spots, it offers crypto copywriting services, placing a crypto project on CoinMarketCap, CoinGecko, and other services to extend cryptocurrency business globally. It has contracts with major advertising agencies in the USA and Europe. In a month, Crypto-Upvotes is planning to enter the media markets of Japan and Korea to provide comprehensive solutions to promote various crypto projects.

Social Links
Website: https://Crypto-Upvotes.com
TG: https://t.me/marketing_crypto
Twitter: https://twitter.com/crypto_upvotes
Instagram: https://www.instagram.com/crypto_upvotes

Media contacts
Crypto Marketing Agency Crypto-Upvotes
Daniel Lazovsky, CEO
founder@Crypto-Upvotes.com

SOURCE: Crypto-Upvotes

Copyright 2022 ACN Newswire. All rights reserved. www.acnnewswire.comCrypto marketing agency Crypto-Upvotes is starting to conquer the Asian market by offering advertisements for crypto projects on billboards in Greater China region. The company will also offer promotions on local social networks such as Wechat & Tiktok. The company is expected to offer similar services in Japan and Korea in a month after the full launch in Greater China.

TheCapitalNet TV intros Into The Private Markets With Cyril Demaria

Tag Template - News Hub PRO CoinGenius Hosts Virtual Crypto Event The Road To Mass Adoption

Menlo Park, CA / Hyderabad, IN, Apr 9, 2022 - (ACN Newswire) - TheCapitalNet TV launches Into The Private Markets with renowned industry expert Cyril Demaria, focusing on understanding the nuances of the private markets ecosystem.

Tag Template - News Hub PRO CoinGenius Hosts Virtual Crypto Event The Road To Mass Adoption

Episode 1 | Into the Private Markets with Cyril Demaria : Asset Classes
Link : http://tcn.one/pvtmarketsep1

With over 20 years of work experience in the private markets, having authored multiple books and research papers, along with being part of multiple funds, consultant to pension funds, family offices, and a PhD from University St. Gallen in addition to being an Affiliate Professor at EDHEC Business School, Cyril Demaria, with his bounty of knowledge about the private market value chain, sits down with TheCapitalNet Team to break down basics of the private markets, starting with the asset classes prevalent in the same.

Cyril Demaria : Author, Academician and Investor
Apoorva : Editor, TheCapitalNet TV
Watch : https://www.thecapitalnet.tv

Stay tuned for Episode 2 focused on key industry players prevalent within these assets classes - exclusively on TheCapitalNet TV.

TheCapitalNet TV (www.thecapitalnet.tv) is a pioneer in producing and publishing original Audio-Visual content with deep insights, knowledge, and resources on Private Markets, Private/Alternative Investments, Venture Capital, Private Equity, Innovation, and startups ecosystem globally. For content suggestions, sponsorships, advertising, or partnerships, please reach out: contact@thecapitalnet.tv, and visit TheCapitalNet TV at https://www.thecapitalnet.tv.

TheCapitalNet TV is the knowledge media arm of TheCapitalNet, Inc.

TheCapitalNet, Inc (www.thecapitalnet.com) is a SaaS company that operates at the intersection of process, intelligence and transactions related to the private markets, including investments (PE, VC, CVCs, Angel Networks, and M&A), innovation (Accelerators and Incubators), and startups. We put the best technologies to work while collaborating with our stakeholders to enable what they do best : value nurturing and wealth creation.

Copyright 2022 ACN Newswire. All rights reserved. www.acnnewswire.comLaunching "Into the Private Markets", an exhaustive series focused on understanding the nuances of this ecosystem with renowned industry expert Cyril Demaria.
Tag Template - News Hub PRO CoinGenius Hosts Virtual Crypto Event The Road To Mass Adoption

ARMA International Forms Global Partnership With The Records and Information Management Professionals Australasia

Tag Template - News Hub PRO CoinGenius Hosts Virtual Crypto Event The Road To Mass Adoption

LEE'S SUMMIT, MO and BURLEIGH HEADS, AU, Apr 8, 2022 - (ACN Newswire) - ARMA International (www.arma.org), the world's leading membership organization serving professionals who manage and govern information assets and the Records and Information Management Professionals Australasia (RIMPA) (www.rimpa.com.au/), the longest serving peak body for industry practitioners in the southern hemisphere announced today a Global Partnership to better serve the information management profession worldwide.

The global partnership between these two leading worldwide organizations will provide many benefits to their collective 7,000 members who will now have the opportunity for joint membership in both organizations; access to reciprocal resources including communities and professional development, education and certifications; and advocacy for the information management and information governance profession. Together the two organizations will work together to provide a unique perspective on global information issues.

"Increasing the influence of the organization in the information management profession globally is a key strategic goal put forth by the ARMA Board of Directors. A partnership between ARMA and RIMPA is an amazing opportunity to create a global alliance for the industry and increase the opportunities for all of our members worldwide," added Michael Haley, President, Board of Directors, ARMA.

"Information management and recordkeeping is a global challenge to do well. For the benefit of world citizens, I see the ARMA and RIMPA alliance as a very important step in meeting this challenge through the exchange of information, sharing resources and good will and I am very proud to part of this exciting journey that we are about to embark on," said Thomas Kaufhold, Chair of Board, RIMPA.

The two organizations have already begun collaborating. Nathan Hughes, Executive Director of ARMA and Wendy McLain, President-Elect of ARMA will be attending the RIMPA Live 2022 Convention, June 14-17 in Canberra, Australia, and participate in meetings with the RIMPA Board. Anne Cornish, Chief Executive Officer of RIMPA and Thomas Kaufhold, Chair of the Board of RIMPA will be attending ARMA's InfoCon 2022, October 16-19, in Nashville, TN, and participate in meetings with the ARMA Board.

"The partnership of ARMA and RIMPA brings with it the opportunity to integrate two of the largest information management communities to continue to increase awareness for the industry. The possibilities expand exponentially when like-minded organizations work globally for their membership and foster an environment of growth," said Nathan Hughes, Executive Director, ARMA.

"A RIMPA and ARMA alliance provide both member groups with the opportunity to broaden their knowledge and extend networking opportunities. Working together on global issues and increasing access to professional development opportunities and resources is a positive sign of how society can operate effectively in separate hemispheres," added Anne Cornish, Chief Executive Officer, RIMPA.

About ARMA International

ARMA International (www.arma.org), formed in 1955, is the world's leading membership organization serving almost 5,000 professionals who manage and govern information in 52 countries. Members represent the community of records management, information management, and information governance professionals who harness the benefits and reduce the risks of information. ARMA provides information professionals with the resources, tools, and training they need to effectively manage records and information within an established information governance framework. Works that are associated with the framework include the Principles, the Information Governance Maturity Model and the Information Governance Body of Knowledge (IGBOK). ARMA recognizes professionals who have mastered these concepts through the Information Governance Professional (IGP) Certification.

About The Records and Information Management Professionals Australasia

The Records and Information Management Professionals Australasia (RIMPA) (www.rimpa.com.au/) established in 1969, represents over 2,000 professionals and organizations in the private sector, Commonwealth, Federal, State and Local Governments. RIMPA has active Branches and Chapters operating in all states and territories across Australia and New Zealand. RIMPA is the longest serving peak body for industry practitioners in the southern hemisphere and actively promotes best practice, sets industry standards and fosters professional development across all business sectors and educational institutions. Through its international partnerships with other peak bodies, RIMPA provides its members with access to an accomplished framework of professional associations. RIMPA has strategic alliances with the Information Governance ANZ, Institute of Managers and Leaders (IML), Australian Library and Information Association (ALIA), Australian Society of Archivist (ASA) and Leadership Through Data.

For further information, contact:
Amy Riemer, Media Relations Representative
978-475-4441 (office) or 978-502-4895 (cell)
amy@riemercommunications.com

SOURCE: ARMA International

Copyright 2022 ACN Newswire. All rights reserved. www.acnnewswire.comARMA International (www.arma.org), the world's leading membership organization serving professionals who manage and govern information assets and the Records and Information Management Professionals Australasia (RIMPA) (www.rimpa.com.au/), the longest serving peak body for industry practitioners in the southern hemisphere announced today a Global Partnership to better serve the information management profession worldwide.

Philanthropic Project, Impact Women NFTs, Launches to Combat Domestic Violence in Brazil

Florianópolis, Brazil, Apr 2, 2022 - (ACN Newswire) - Impact Women NFT, a philanthropic project displaying exquisite artworks handmade by a talented artist, has announced the launch of its NFT project. Aimed at combating domestic violence in the previously mentioned South American country, these beautifully crafted NFTs were created by renowned, talented, and award-winning illustrator Manu Cunhas.

Tag Template - News Hub PRO CoinGenius Hosts Virtual Crypto Event The Road To Mass Adoption

Designed by Brazilian fintech to fight the scourge of domestic violence and abuse of women, Impact Women NFT will raise funds for non-profit organizations to take a stand against women's abuse on all levels.

Current statistics show that domestic violence is at an all-time high. Brazil sits fifth in the ranking of homicides globally; one woman gets raped every eleven minutes. Five hundred and three women suffer aggression every hour, one woman gets killed every two hours, and five beatings occur every two minutes.

Impact Women NFT is fighting to put an end to these crimes.

Profit Shared to Non-profit Organization, Artist, and Project Producer

Split into phases, the first one comprising 20 excellent, awe-inspiring, and elegantly designed artworks of remarkable and high-impact women in history, each of these NFT auctions will greatly benefit non-profit organizations. The goal of the first phase is to raise 30 ETH, ten in auction mode starting at the price of 0.15 ETH and ten in 50 units for a fixed fee of 0.05 ETH.

Impact Women NFT has hand-picked eight exciting and industrious non-profits aggressively fighting violence against women in Brazil. 70% of profits garnered from these NFTs sales will be set aside for organizations, 12% to support Manu Cunhas, another 12% for Doare—the project producer and social enterprise company—and 6% for carbon credits through MOSS.

The campaign will end on May 31st, 2022, and Impact Women NFT will offer rewards and surprises like special parties and airdrops in the metaverse.

A project where art meets philanthropy, Impact Women NFT, will share stories of amazing women that have changed society. The founding team selects ten Brazilian and international women to show respect and admiration for the work they have put in.

An Ambitious Roadmap

Built on sustainability and longevity, Impact Women NFT has introduced a viable and strategic roadmap comprising detailed future events. Divided into separate phases, Impact Women NFT plans to run a decentralized autonomous organization [DAO], create and launch a native token, and a non-profit crypto fund to support organizations combating domestic violence and other forms of abuse against women.

Additionally, Impact Women NFT will continue to create and release amazing, unique, well-designed, and aesthetically pleasing artworks to support life-changing non-profits.

About Impact Women NFT

Impact Women NFT is a philanthropic project that displays magnificent and well-crafted artworks made by Manu Cunhas. Aimed at combating domestic violence, Impact Women NFT will fund existing non-profits championing and empowering women in the country and beyond.

Social Links
Twitter: https://twitter.com/impactwomen_nft
Instagram: https://www.instagram.com/impactwomen.nft
Telegram: https://t.me/impactwomenNFT
Discord: https://discord.gg/QdGktzSJyg

Media Contact
Project Name: Impact Women NFT
Contact: Caroline Alencar, Marketing Director
Email: info@impactwomen.org
Website: https://impactwomen.org/

SOURCE: Impact Women NFT



Copyright 2022 ACN Newswire. All rights reserved. www.acnnewswire.com

Official Listing of Recbio on HKEX, Vaccine Innovation and Iteration Accelerated by Novel Adjuvant Technology

HONG KONG, Apr 1, 2022 - (ACN Newswire) - On March 31, the China-based novel vaccines company - Jiangsu Recbio Technology Co., Ltd. ("Recbio" or the "Company", Stock Code: 2179.HK) went public and was officially listed on the Hong Kong Stock Exchange. Assuming the Over-allotment option is not exercised, 30,854,500 H shares were issued under the Global Offering, with a price of HK$24.80 per share and proceeds up to approximately HK$765 million. The Hong Kong public Offering received an enthusiastic response from investors and was over-subscribed by more than 9.65 times. As the cornerstone investors of the Company, the cornerstone subscription ratios of Yangtze River Pharmaceutical, Harvest Global and Sequoia China exceed 50%. Previously, the Company has won the favor of many well-known investment institutions, including Legend Capital, LYFE Capital, Oriental Fortune Capital, Fer-Capital, Sequoia China, CMB International, Lake Bleu and Temasek. Having successfully listed in Hong Kong, becoming "the first HPV vaccine stock in Hong Kong" and "the first novel adjuvant vaccine stock in Hong Kong", Recbio is expected to inject new vitality into the capital market in Hong Kong.

Tag Template - News Hub PRO CoinGenius Hosts Virtual Crypto Event The Road To Mass Adoption

Tag Template - News Hub PRO CoinGenius Hosts Virtual Crypto Event The Road To Mass Adoption

Tag Template - News Hub PRO CoinGenius Hosts Virtual Crypto Event The Road To Mass Adoption
Chart: Innovative vaccine portfolio of Recbio

Tag Template - News Hub PRO CoinGenius Hosts Virtual Crypto Event The Road To Mass Adoption

Domestic vaccine innovation and iteration accelerated by novel adjuvant technology

Vaccines are praised as the "golden track" in the medical health field. According to the Frost & Sullivan report, from 2016 to 2020, the size of the global vaccine market has increased from US$27.5 million to US$39.9 billion at a CAGR of 9.7%, while the CAGR of global pharmaceutical market was only 3.02%. China has become the second largest vaccine market globally, with the market volume increased from RMB27.1 billion in 2016 to RMB75.3 billion in 2020 at a CAGR of 29.1%.

Regarding the insufficient domestic supply of and the unmet urgent demand for novel vaccines, it has become an important part of the Development Planning of the Pharmaceutical Industry in the "14th Five-Year Plan" in China (referred as the "Plan") to promote enterprises to speed up the development of related products and to achieve product availability as soon as possible. Regarding the development of the vaccine industry, the "Plan" also states that research and development of novel vaccines (such as novel adjuvants for vaccines and mRNA vaccines) and building of industrialization capability shall be accelerated. It also emphasizes on the development of novel COVID-19 vaccines, herpes vaccines, polyvalent human papillomavirus (HPV) vaccines and other products.

As an innovative novel vaccine company, Recbio has constructed the three core technology platforms consisting of novel adjuvants, protein engineering and immunological evaluation, forming synergy in antigen design and optimization, adjuvant development and production, identification of the best combination of antigen and adjuvants. The Company has built a comprehensive and high-valued vaccine portfolio consisting of 12 candidates, covering cervical cancer, COVID-19, adult tuberculosis, shingles, HFMD, influenza etc. It covers five of the ten diseases with the greatest burden under the 2019 Global Burden of Diseases issued by the World Health Organization and disease areas of the three of the top five globally bestselling vaccine products in 2020.

Novel adjuvant for vaccines is the "bottleneck" technology of innovative vaccines. Through years of technical research, Recbio has successfully achieved independent control of all FDA-approved novel adjuvants, and is one of the few companies in the world capable of independent development of novel adjuvants. It has also successfully applied in various innovative vaccines such as COVID-19 vaccines, HPV vaccines and shingles vaccines.

A moat constructed with a rich product portfolio

HPV vaccines are one of the most commercially valuable vaccines in the world. It is expected that there will be 234 million females in China aged 9-45 unvaccinated for HPV in 2025 assuming 3 doses per person, requiring additional 702 million doses. Currently, Recbio has formed a full coverage of bivalent, quadrivalent and 9-valent vaccines and novel adjuvant upgrades in the field of HPV vaccines. The core product REC603, a recombinant HPV 9-valent vaccine is currently under phase III clinical trial, expected to become the first approved domestic HPV 9-valent vaccine. Regarding the global immunization program market, REC601, a bivalent vaccine has the potential to become one of the most popular vaccine options. At the same time, the Company is also in the process of developing second-generation HPV vaccines, namely REC604a (a quadrivalent vaccine) and REC604b (a 9-valent vaccine). Both vaccines have adopted our self-developed novel adjuvants and are expected to achieve two-shot regimens in the future. The construction of the first phase of the HPV manufacturing facility of Recbio is expected to be completed by the end of this year. By then, it will realize the designed capacity of five million doses of HPV 9-valent vaccines or 30 million doses of HPV bivalent vaccines per year. As the first cancer preventive vaccine in the world, HPV vaccines have been in shortage for a long time. With the gradual release of domestic HPV vaccines in the future and the gradual release of production capacity, domestic substitution will be accelerated.

Protein engineering, novel adjuvant and other technology are comprehensively used in ReCOV, the COVID-19 vaccine of Recbio, to thoroughly optimize the vaccine, allowing ReCOV to possess a series of comprehensive advantages, including excellent safety, strong immunogenicity, strong cross-protection effectiveness with Omicron and Delta mutant strains, easy-to-scale-up production, low production cost, high preparation stability, storage and transportation in room temperature etc. The international phase II/III clinical trials of such vaccine are currently in progress. EUA/BLA applications are estimated to be submitted in 2022. On the side of production supply, the Company has completed the construction of our GMP-standard manufacturing facility for ReCOV and obtained the drug production license in November 2021. The manufacturing facility has a total GFA of approximately 17,000 sq.m., has the potential to support an annual manufacturing capacity of 300 million doses of ReCOV and can be used to manufacture recombinant shingles vaccines.

In the field of shingles vaccines, shingles virus is dormant in almost all adults over 50 of age in China, affecting approximately 2.5 million adults in China every year. However, Shingrix is currently the only shingles vaccine approved in China. The novel adjuvant which benchmarking AS01 is adopted in REC610 of the Company, significantly improving vaccine immunogenicity, hoping to achieve domestic substitution quickly.

Recogen, our subsidiary has first achieved technology breakthrough in lyophilized mRNA vaccines. It has applied the self-developed freeze-drying technology to achieve preparation stability at 4 degrees Celsius and 25 degrees Celsius, allowing storage and transportation under general cold-chain conditions, effectively solving the current defect in availability of mRNA vaccines.

"We are glad that the Hong Kong stock IPO has been highly recognized by the capital market. The successful listing of Recbio is expected to bring more confidence to the Hong Kong 18A stock market. Thanks to all the investors for their strong support, we were able to successfully go public as originally planned in such extremely depressed environment of the Hong Kong capital market!" Regarding the listing of Recbio in Hong Kong, Dr. Liu Yong, the Founder, Chairman of the Board, and General Manager of Recbio stated that, "Against the backdrop of a huge global demand for innovative vaccines in this era, through continuous innovation and international cooperation, we will accelerate the commercialization of products in the global market, promote innovation in the entire value chain of the vaccine industry from R&D to commercialization, and create greater value for shareholders and investors. Today is the beginning of a brand-new journey for Recbio. I hope that all investors will continue to support our Company. Let's hope we will continue to move forward hand in hand, through the sweltering summer and winter, and create new glory together!"

About Recbio
Founded in 2012, Recbio is an innovative vaccine company with independent research and development technology as its core driving force. It is committed to building a full value chain of innovative vaccines, covering research and development, production and commercialization. The Company has always adhered to the mission of "creating first-class vaccines and protecting human health". With a strong research and development engine comprising of novel adjuvants, protein engineering, immunological evaluation and other core technology platforms, strategically focusing on disease areas with significant burden such as cervical cancers COVID-19, shingles, adult TB, HFMD and flu etc., the Company has established a high-value product pipeline consisting of 12 vaccine candidates with independent intellectual property rights, in order to meet the under-fulfilled public health needs. For more information, please visit https://www.recbio.cn/.


Copyright 2022 ACN Newswire. All rights reserved. www.acnnewswire.comOn March 31, the China-based novel vaccines company - Jiangsu Recbio Technology Co., Ltd. ("Recbio" or the "Company", Stock Code: 2179.HK) went public and was officially listed on the Hong Kong Stock Exchange.

What You Need to Know about Polkadot (DOT) in 2022

Tag Template - News Hub PRO CoinGenius Hosts Virtual Crypto Event The Road To Mass Adoption

SINGAPORE, Apr 1, 2022 - (ACN Newswire) - 2021 was a huge year for the cryptocurrency market, with huge strides in growth and adoption of digital assets, NFTs, and blockchain worldwide. It was also an incredible year for Moonstake as we rose the top rankings of global staking providers, reaching a total staking assets of $1.8 billion thanks to the support of our users and partners worldwide. As we begin the new year 2022, Moonstake as well as our strategic coin partners have many exciting news and programs in store for you as our platforms scale and evolve. To welcome our user community into the exciting new year, we're creating a series of articles in collaboration with our strategic partner on what you need to know about our partner coins in the year 2022, this time with Polkadot.

Tag Template - News Hub PRO CoinGenius Hosts Virtual Crypto Event The Road To Mass Adoption

As of January 2020, Moonstake has been supporting DOT staking via strategic partnership with RockX, one of Polkadot's leading node operators. Since then, Moonstake has hosted a number of campaigns that promote awareness of the Polkadot ecosystem as well as adoption of DOT staking to global users, including webinars and giveaways. Later, Moonstake also partnered with Plasm, now known as Astar Network, a leading DApps hub on Polkadot, to expand support for the ecosystem with other parachains.

In 2021, Polkadot accomplished a number of major development milestones with the rollout of Parachains, Slot Auctions, and Crowdloans across 2 Relay-chain networks: Kusama coming live early in the year and Polkadot following up in December, both of which saw numerous successful parachain launches following their establishments. Additionally, the number of nominator accounts the network can support has tripled from 6,000 at the end of 2020 to 22,000 at its peak. In terms of organized events, Polkadot also managed to participate in over 380 meetups and conferences across the globe, both online and offline,in its effort to cultivate the global Polkadot community against the turbulence caused by the pandemic. Most notably, Polkadot received support and endorsement from the largest telecom company in Europe, Deutsche Telekom, who is currently using its infrastructure to participate in the Polkadot public blockchain network as a validator.

For 2022, Polkadot is focusing on expanding the number of Parachains on their network, with the ultimate goal being 100 parachain slots total. The project is also strongly continuing to push its efforts in building a robust development community for the ecosystem through even more events, hackathons, and initiatives. Not only will this help propel the ecosystem to greater heights in terms of technical achievements and usability, it is also how Polkadot will grow its user base and attract the interests of investors looking for high-value ecosystems.

Moonstake is proud to be strategic partners of Astar to expand the Polkadot ecosystem.We will continue to maintain strong support for the ever growing and developing Polkadot ecosystem and hope to bring even more great value to DOT and crypto users worldwide in 2022 to help accelerate adoption of the Polkadot and Moonstake ecosystems together.

About Moonstake

As a world-leading staking service provider, Moonstake develops and operates decentralized wallet services for enterprises and end users.

Our full-scale staking business started in August 2020. With the support of users all over the world, our total staking assets has risen to 1.8 billion dollars. In June 2021, we ranked third among 15,000 staking providers globally.

So far, we have expanded our business and ecosystem through about 30 strategic partnerships, including major blockchains such as Emurgo which is a constituent organization of Cardano, TRON, and NEO. In May 2021, we became a wholly owned subsidiary of the listed company "OIO Holdings Limited" on the Singapore Stock Exchange and we are working to further expand Moonstake's business and improve our credibility. https://www.moonstake.io/

About Polkadot

Polkadot will enable a completely decentralized web where users are in control.

Polkadot is built to connect private and consortium chains, public and permissionless networks, oracles, and future technologies that are yet to be created. Polkadot facilitates an internet where independent blockchains can exchange information and transactions in a trustless way via the Polkadot relay chain.

Polkadot makes it easier than ever to create and connect decentralized applications, services, and institutions. By empowering innovators to build better solutions, we seek to free society from its reliance on a broken web where its large institutions can't violate our trust. https://polkadot.network/

About Astar

Astar Network is the #1 Smart Contract Hub for WASM + EVM on Polkadot. Since winning its Parachain auction in January 2022, Astar Network has become the top Parachain in the Polkadot ecosystem in terms of Total Value Locked and most Ethereum assets transferred over. Astar Network is the leading smart contract hub that connects the Polkadot ecosystem to Ethereum, Cosmos, and all major layer 1 blockchains. Astar Network supports dApps using multiple virtual machines - namely WASM and EVM - and offers the best technology solutions and financial incentives via its Build2Earn and Astar Incubation Program for Web3 developers to build on top of a secure, scalable and interoperable blockchain. https://astar.network/

Copyright 2022 ACN Newswire. All rights reserved. www.acnnewswire.comAs of January 2020, Moonstake has been supporting DOT staking via strategic partnership with RockX, one of Polkadot's leading node operators.

Resolving The Latency Dilemma Of Blockchain Technology

Resolving The Latency Dilemma Of Blockchain Technology
Blockchain technology and the vivid range of products and services built upon it are touted as the “key drivers” of the next wave of innovation across the traditional and digital ecosystems. The transition from Web2 to Web3 is happening faster than ever, as is evident from the growing popularity of blockchain-native applications. In the last […]

Announcement of Establishment of CA GameFi, Inc․ For Developing Blockchain Games in the Global Market

Tag Template - News Hub PRO CoinGenius Hosts Virtual Crypto Event The Road To Mass AdoptionPRESS RELEASE. CA GameFi Inc., (headquartered in Shibuya-ku, Tokyo, Japan; Taro Yamamoto, Representative Director; hereafter CA GameFi), a subsidiary of CyberAgent Inc. (headquartered in Shibuya-ku, Tokyo, Japan; Makoto Fujita, Representative Director; listed on the TSE’s first section, Stock Code 4751; hereafter CyberAgent), now announces the establishment of the company to run blockchain game business on […]
Tag Template - News Hub PRO CoinGenius Hosts Virtual Crypto Event The Road To Mass Adoption

Recent articles

spot_img